308 related articles for article (PubMed ID: 18955011)
1. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
Prabhu S; Kaveri H; Rekha K
Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin expression in benign and malignant salivary gland tumors.
Chandrashekar C; Angadi PV; Krishnapillai R
Int J Surg Pathol; 2011 Aug; 19(4):433-40. PubMed ID: 20034989
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin and E-cadherin expression in salivary gland tumors.
Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
[TBL] [Abstract][Full Text] [Related]
4. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
5. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
[TBL] [Abstract][Full Text] [Related]
10. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
12. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
13. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
14. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
15. [Bcl-2 gene protein expression in salivary gland tumors].
Yáñez M; Roa I; García M; Ibacache G; Villaseca M
Rev Med Chil; 1999 Feb; 127(2):139-42. PubMed ID: 10436692
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like Growth Factor II Messenger RNA-binding Protein 3 in Salivary Gland Tumors.
Ismerim AB; Ferreira SV; Lessa AM; Pereira Júnior AS; Gurgel CA; Coutinho-Camillo CM; Soares FA; Vilas-Bôas DS; Vidal MT; Santos JN
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):422-6. PubMed ID: 26258757
[TBL] [Abstract][Full Text] [Related]
17. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
[TBL] [Abstract][Full Text] [Related]
20. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]